Keyphrases
Adverse Events
6%
AIDS/HIV
25%
All-cause Mortality
6%
Antibody Response
7%
Antiretroviral Therapy
41%
Antiretroviral Therapy Initiation
5%
Antiviral Drugs
5%
Body Mass Index
5%
Cardiovascular Disease
9%
Cardiovascular Risk
9%
CD4 Count
17%
Chondroitin Sulfate
5%
Chronic Kidney Disease
5%
Chronic Obstructive Pulmonary Disease
5%
Clinical Outcomes
7%
Combined Antiretroviral Therapy (cART)
13%
Comorbidity
10%
Confidence Interval
37%
Copenhagen
10%
COVID-19
30%
Cystic Fibrosis
14%
Cytomegalovirus
5%
D Study
7%
Denmark
45%
Diabetes
5%
Donor-acceptor
9%
During Exercise
8%
Eastern Europe
5%
Europe
22%
EuroSIDA
7%
Exercise Training
5%
Exercise-induced
5%
Falciparum Malaria
7%
Ghana
5%
Greenland
5%
Hazard Ratio
8%
Healthy Controls
5%
Healthy Individuals
5%
Hepatitis C
5%
Hepatitis C Virus
12%
High Risk
7%
Highly Active Antiretroviral Therapy (HAART)
8%
HIV Infection
19%
HIV Patients
42%
HIV RNA
6%
HIV-positive
17%
Hospitalization
5%
Hospitalized Patients
5%
Human Immunodeficiency Virus Infection
5%
Human Immunodeficiency Virus Type 1 (HIV-1)
19%
Human Skeletal muscle
7%
Immune Response
5%
Incidence Rate
13%
Infected Erythrocytes
10%
Infected Individual
6%
Infected Patients
8%
Infectious Diseases
5%
Inflammation
9%
Insulin Resistance
8%
Insulin Sensitivity
5%
Interleukin-6
16%
Malaria
20%
Malaria Vaccine
6%
Meningitis
5%
Mortality Rate
5%
Mycobacterium Tuberculosis (M. tb)
6%
Myocardial Infarction
6%
National Cohort Study
26%
Nave
5%
Non-AIDS Comorbidities
6%
Non-associated
6%
Odds Ratio
6%
Patients with COVID-19
5%
People Living with HIV (PLHIV)
40%
PfEMP1
13%
Placental Malaria
7%
Plasmodium Falciparum
35%
Polymorphism
5%
Pregnant Women
6%
Prospective Cohort Study
7%
Randomized Controlled Trial
9%
Randomized Trial
7%
Rheumatoid Arthritis
7%
Risk Factors
17%
Severe Malaria
5%
Skeletal muscle
17%
Solid Organ Transplant Recipients
5%
Sub-Saharan Africa
5%
Systemic Lupus Erythematosus
6%
Tanzania
9%
Tuberculosis
15%
Tumor Necrosis Factor-α
6%
Type 2 Diabetes Mellitus (T2DM)
12%
Vaccination
7%
VAR2CSA
12%
Viral Load
8%
Virological Failure
5%
Medicine and Dentistry
Adverse Event
5%
Antiretroviral Therapy
26%
Arm
5%
Biological Marker
6%
Body Mass Index
5%
Cardiovascular Disease
8%
Cell Count
6%
Cohort Analysis
35%
COVID-19
19%
Cross Sectional Study
8%
Cystic Fibrosis
10%
Diabetes
6%
Diabetes Mellitus
5%
Diagnosis
7%
Disease
20%
Hazard Ratio
7%
Hepatitis C
6%
Hepatitis C Virus
8%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
11%
Infection
37%
Insulin Resistance
5%
Intensive Care Unit
5%
Malignant Neoplasm
10%
Maturity Onset Diabetes of the Young
8%
Odds Ratio
7%
Population
7%
Prevalence
14%
Prospective Cohort Study
6%
Randomized Controlled Trial
6%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Skeletal Muscle
16%
Symptom
10%
Systematic Review
5%
Transplantation
5%